Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine Besylate versus Placebo)
Amlodipine Besylate Tablet
Product Images NDC 65862-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 65862-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Effects on Primary Endpoint of Amlodipine Besylate versus Placebo across Sub-Groups)
Package Label-principal Display Panel (2.5 mg (30 Tablets Bottle))
This is a medication called Amlodipine Besylate in the form of tablets. The manufacturer is Aurobindo Pharma U of East Windsor, with a code of TS/DRUGS/19/1993. Each tabit contains 2.5 mg of amlodipine, and the usual dosage should be found in the package insert. It should be stored at a temperature of 20°C to 57°C, with excursions permitted from 15°C to 50°C. These tablets should be protected from light. There is also a coding area with dotted lines that should not be printed.*
Package Label-principal Display Panel (5 mg (30 Tablets Bottle))
This is a medication package for Amlodipine Besylate Tablets, USP manufactured by Aurobindo Pharma USA, Inc. The package includes 30 tablets, each containing 5mg of amlodipine besylate. The usual dosage and storage recommendations are also provided. The package is meant to be dispensed in light-resistant containers. No other information is available.*
Package Label-principal Display Panel (10 mg (30 Tablets Bottle))
Chemical Structure (Amlodipine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
